GAM Holding’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,937
Closed -$207K 384
2019
Q4
$207K Sell
1,937
-28,391
-94% -$2.96M 0.01% 531
2019
Q3
$3.25M Buy
30,328
+1,625
+6% +$167K 0.14% 167
2019
Q2
$2.92M Sell
28,703
-1,757
-6% -$169K 0.11% 202
2019
Q1
$2.74M Sell
30,460
-5,081
-14% -$440K 0.12% 202
2018
Q4
$2.96M Sell
35,541
-7,998
-18% -$750K 0.15% 162
2018
Q3
$4.7M Buy
43,539
+5,749
+15% +$631K 0.17% 148
2018
Q2
$4.15M Buy
37,790
+2,888
+8% +$301K 0.14% 168
2018
Q1
$3.5M Sell
34,902
-3,516
-9% -$360K 0.12% 194
2017
Q4
$3.78M Buy
38,418
+11,638
+43% +$1.1M 0.12% 215
2017
Q3
$2.51M Sell
26,780
-40,726
-60% -$4.32M 0.11% 228
2017
Q2
$7.5M Buy
67,506
+22,876
+51% +$2.42M 0.11% 233
2017
Q1
$4.38M Hold
44,630
0.07% 346
2016
Q4
$4.1M Sell
44,630
-24,966
-36% -$2.15M 0.07% 311
2016
Q3
$5.89M Sell
69,596
-50,450
-42% -$4.24M 0.1% 227
2016
Q2
$9.77M Buy
120,046
+47,995
+67% +$3.65M 0.15% 167
2016
Q1
$5.15M Sell
72,051
-5,845
-8% -$392K 0.09% 260
2015
Q4
$5.54M Buy
77,896
+427
+0.6% +$28.7K 0.09% 242
2015
Q3
$4.76M Buy
77,469
+8,787
+13% +$614K 0.08% 265
2015
Q2
$4.98M Buy
68,682
+5,880
+9% +$434K 0.07% 294
2015
Q1
$4.83M Buy
62,802
+3,815
+6% +$273K 0.07% 301
2014
Q4
$3.96M Buy
58,987
+10
+0% +$631 0.06% 332
2014
Q3
$3.58M Sell
58,977
-453
-0.8% -$27.9K 0.05% 366
2014
Q2
$3.49M Sell
59,430
-1,400
-2% -$82K 0.05% 367
2014
Q1
$3.52M Buy
60,830
+10,630
+21% +$570K 0.06% 361
2013
Q4
$2.69M Buy
50,200
+7,941
+19% +$471K 0.05% 381
2013
Q3
$2.61M Buy
42,259
+649
+2% +$38.8K 0.05% 392
2013
Q2
$2.52M Buy
+41,610
New +$2.48M 0.06% 353

Other funds holding DGX

GAM Holding's DGX Position: Q1 2020 in Review

GAM Holding sold out of Quest Diagnostics (DGX) in Q1 2020, closing a stake of 1,937 shares — an estimated $207K sold.

GAM Holding first reported a position in DGX in Q2 2013 and held it in 27 quarters. The position peaked at $9.77M in Q2 2016. 714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

  • GAM Holding reported no remaining Quest Diagnostics position as of Q1 2020 after selling out during the quarter.
  • GAM Holding sold 1,937 Quest Diagnostics shares in Q1 2020, an estimated $207K.
  • GAM Holding first reported a position in Quest Diagnostics in Q2 2013 and held it in 27 quarters.
  • GAM Holding's Quest Diagnostics position peaked at $9.77M in Q2 2016.
  • 714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on GAM Holding's 13F filing for Q1 2020, filed 12 May 2020.